NeuroVasc Secures $34 Million in Funding to Support Clinical Trials and Product Development

Feb 27, 2020•almost 6 years ago

Amount Raised

$34 Million

Irvine

Description

NeuroVasc Technologies, Inc. announced that it has entered into a strategic partnership with the Wego Group that includes $34 million in funding to support the company’s product portfolio development and global clinical trial program.

Company Information

Company

Neuro Vasc

Location

Irvine, California, United States

About

NeuroVasc Technologies, Inc. is a private company founded in 2015 and dedicated to advancing neurovascular innovation. Unlike other start-ups, NeuroVasc efforts are not just to develop a single product or single family of products, but to assemble a leading catalogue of internally developed and to address unmet needs in the treatment of neurovascular disease. Its current core product is a next-generation mechanical thrombectomy system that is designed to improve = clot retrieval capabilities in tortuous anatomy. NeuroVasc has received a CE Mark and is commercially active in Europe and Hong Kong, with 2020 commercial sales activity planned to expand into South America and Southeast Asia.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

NeuroVasc Secures $34 Million in Funding to Support Clinical Trials and Product Development

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information